Aranesp vs Neupogen
Did you mean taking both Aranesp and Neupogen?
Neupogen is a granulocyte Colony-Stimulating factor (G-CSF).
September 17, 2001
February 20, 1991
Number of discussions around the web Number of discussions + -
Side Effects and Concerns
Pregnancy Category (FDA) OpenClose all pregnancy categories
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
FDA has not classified the drug.
Before taking Aranesp during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Before taking Neupogen during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
There may be a negative interaction between Aranesp and alcohol.
There may be a negative interaction between Neupogen and alcohol.
Method of use
Syringe: 60 mcg/0.3 mL, 150 mcg/0.3 mL, 10 mcg/0.4 mL, 40 mcg/0.4 mL, 200 mcg/0.4 mL, 25 mcg/0.42 mL, 100 mcg/0.5 mL, 300 mcg/0.6 mL, 500 mcg/mL
Injector: 60 mcg/0.3 mL, 150 mcg/0.3 mL, 40 mcg/0.4 mL, 200 mcg/0.4 mL, 25 mcg/0.42 mL, 100 mcg/0.5 mL, 300 mcg/0.6 mL, 500 mcg/mL
Solution: 150 mcg/0.75 mL, 25 mcg/mL, 40 mcg/mL, 60 mcg/mL, 100 mcg/mL, 200 mcg/mL, 300 mcg/mL
Syringe: 300 mcg/0.5 mL, 300 mcg/0.5mL, 480 mcg/0.8 mL, 480 mcg/0.8mL
Solution: 480 mcg/1.6 mL, 300 mcg/mL
No Food Instructions
No Food Instructions
Darbepoetin Alfa In Albumn Sol , Darbepoetin Alfa In Polysorbat
Interaction between Aranesp and Neupogen: Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
content loaded dynamically
We found 249 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.